These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32389124)

  • 21. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
    Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-Resistant Acinetobacter baumannii Ventriculostomy-Related Infection, Treated by a Colistin, Tigecycline, and Intraventricular Fibrinolysis.
    Perier F; Couffin S; Martin M; Bardon J; Cook F; Mounier R
    World Neurosurg; 2019 Jan; 121():111-116. PubMed ID: 30312816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.
    Chusri S; Sakarunchai I; Kositpantawong N; Panthuwong S; Santimaleeworagun W; Pattharachayakul S; Singkhamanan K; Doi Y
    Int J Antimicrob Agents; 2018 Apr; 51(4):646-650. PubMed ID: 29241820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.
    Rigatto MH; Vieira FJ; Antochevis LC; Behle TF; Lopes NT; Zavascki AP
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6575-80. PubMed ID: 26259799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study.
    Sipahi OR; Mermer S; Demirdal T; Ulu AC; Fillatre P; Ozcem SB; Kaya Ş; Şener A; Bulut C; Tekin R; Kahraman H; Özgiray E; Yurtseven T; Sipahi H; Arda B; Pullukçu H; Taşbakan M; Yamazhan T; Aydemir S; Ulusoy S
    Clin Neurol Neurosurg; 2018 Sep; 172():31-38. PubMed ID: 29960893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactam.
    Fitzpatrick MA; Esterly JS; Postelnick MJ; Sutton SH
    Ann Pharmacother; 2012; 46(7-8):e17. PubMed ID: 22811349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
    Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
    Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii.
    Rao GG; Ly NS; Diep J; Forrest A; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2016 Sep; 48(3):331-6. PubMed ID: 27449542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal arachnoiditis followed by intrathecal tigecycline therapy for central nervous system infection by extremely drug-resistant
    Li LM; Zheng WJ; Shi SW
    J Int Med Res; 2020 Jul; 48(7):300060520920405. PubMed ID: 32628870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tigecycline salvage therapy for ventriculoperitoneal shunt meningitis due to extensively drug-resistant Acinetobacter baumannii.
    Polat M; Ozkaya-Parlakay A
    Eur J Pediatr; 2019 Jan; 178(1):117-118. PubMed ID: 30353221
    [No Abstract]   [Full Text] [Related]  

  • 35. iTRAQ-Based Differential Proteomic Analysis Reveals the Pathways Associated with Tigecycline Resistance in Acinetobacter baumannii.
    Yang N; Liu Y; He P; Ke R; Zhao Y; Feng Y; Jing R; Ma S; Liu C; Geng Y; Wu X; Wei Y
    Cell Physiol Biochem; 2018; 51(3):1327-1339. PubMed ID: 30481750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular epidemiology and resistance mechanisms of tigecycline-non-susceptible Acinetobacter baumannii].
    He X; Li H; Wang Q; Zhao C; Li S; Wang X; Zhang Y; Wang R; Yin Y; Jin L; Zhang F; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1218-1225. PubMed ID: 30152207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature.
    Piparsania S; Rajput N; Bhatambare G
    Turk J Pediatr; 2012; 54(5):548-54. PubMed ID: 23427525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.